Anti-CCP antibodies are associated with early age at onset in patients with rheumatoid arthritis

被引:13
|
作者
Diaz, Francisco J. [2 ]
Rojas-Villarraga, Adriana [1 ]
Salazar, Juan C. [3 ]
Iglesias-Gamarra, Antonio [4 ]
Mantilla, Ruben D. [1 ,5 ]
Anaya, Juan-Manuel [1 ]
机构
[1] Univ Rosario, Ctr Autoimmune Dis Res CREA, Sch Med & Hlth Sci, Bogota, Colombia
[2] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS USA
[3] Univ Nacl Colombia, Dept Stat, Medellin, Colombia
[4] Univ Nacl Colombia, Rheumatol Unit, Bogota, Colombia
[5] Riesgo Fractura CAYRE IPS, Rheumatol Unit, Bogota, Colombia
关键词
Rheumatoid arthritis; Age; HLA-DRB1; TNF-308 A allele; Rheumatoid factor; Anti-CCP antibodies; Smoking; SHARED EPITOPE; ALLELES; DISEASE; HLA; AUTOANTIBODIES; SUSCEPTIBILITY; POLYARTHRITIS; HYPOTHESIS; SEVERITY; SYMPTOMS;
D O I
10.1016/j.jbspin.2010.07.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To determine factors influencing the age at onset of rheumatoid arthritis (RA). Methods: A sample of 152 Colombian patients was investigated. Hazard ratios (HRs) that measured the effect size of risk factors on the age at RA onset were computed by using Cox regression models. Results: Positive anti-CCP antibodies were associated with an increased risk of early RA onset (HR = 1.60; 95% confidence interval, [1.06, 2.4]), whereas the presence of the protective (70)DERAA(74) sequence was associated with a delayed onset (HR = 0.55; [0.33, 0.92]). After controlling for both anti-CCP antibodies and the (70)DERAA(74) sequence, the following variables did not influence significantly the age at RA onset: gender, ever cigarette smoking, family RA history, the TNF-308 A polymorphism, HLA shared epitope, and the presence of rheumatoid factor. Conclusion: Anti-CCP antibodies and the HLA-DRB1 (70)DERAA(74) sequence influence the age at onset of RA. (C) 2010 Societe francaise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:175 / 178
页数:4
相关论文
共 50 条
  • [1] Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis
    N. Inanc
    E. Dalkılıc
    S. Kamalı
    E. Kasapoglu-Günal
    Y. Elbir
    H. Direskeneli
    M. Inanc
    [J]. Clinical Rheumatology, 2007, 26 : 17 - 23
  • [2] Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis
    Inanc, N.
    Dalkilic, E.
    Kamali, S.
    Kasapoglu-Gunal, E.
    Elbir, Y.
    Direskeneli, H.
    Inanc, M.
    [J]. CLINICAL RHEUMATOLOGY, 2007, 26 (01) : 17 - 23
  • [3] Smoking habits and anti-CCP antibodies in patients with Rheumatoid Arthritis
    Chirea, G.
    Sarbu, I.
    Mangaloiu, D.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2017, 27 : 417 - 417
  • [4] Anti-CCP Antibodies: an Emerging Marker for the Early Diagnosis of Rheumatoid Arthritis
    Sarah, K.
    Nadeem, A.
    [J]. INTERNATIONAL MEDICAL JOURNAL MALAYSIA, 2010, 9 (01) : 63 - 65
  • [5] Clinical significance of anti-CCP antibodies in rheumatoid arthritis
    Mimori, T
    [J]. INTERNAL MEDICINE, 2005, 44 (11) : 1122 - 1126
  • [6] THE ANALYSIS OF ANTI-CCP ANTIBODIES AND ITS ACTIVATION IN PATIENTS WITH ARTHRITIS RHEUMATOID
    Saghiri, R.
    Ebrahimi, M.
    Sharif, R. P.
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 235 - 236
  • [7] Test patients with rheumatoid arthritis for anti-CCP antibodies, says NICE
    Mayor, Susan
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2018, 360
  • [8] The analysis of anti-CCP antibodies and its activation in patients with arthritis rheumatoid
    Saghiri, R.
    Ebrahimi-Rad, M.
    Sharif, P.
    [J]. IMMUNOLOGY, 2011, 135 : 176 - 176
  • [9] The clinical utility of anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis
    Simsek, Ismail
    [J]. EUROPEAN JOURNAL OF RHEUMATOLOGY, 2014, 1 (02) : 49 - 50
  • [10] ROLE OF ANTI-CCP ANTIBODIES AND RHEUMATOID FACTOR IN DIAGNOSIS OF RHEUMATOID ARTHRITIS
    Sarkic, M.
    Obradovic, S.
    Jankes, M.
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S218 - S218